HSBC
-
UK pharma latest high rated company to hit the euro market this week -
Dutch issuer’s success suggests long term investors are looking to add riskier debt
-
Greater China issuers dominate this week’s supply, as rare Indian credit HDFC Bank also returns after almost a decade
-
After two successful euro benchmarks, the Dutch agency has set sights on the dollar market
-
Contrasting approaches as BNG takes tried and tested trade while Ned Waters flies solo
-
Finnish issuer achieved bigger size than expected despite tight pricing
-
Second strong outing for top tier issuer leaves question over investor demand for weaker names
-
Sub-sovereign takes more than €6bn of orders, despite the EU keeping investors busy
-
Issuer tightens pricing and gets a conversion premium that is good for it
-
The issuer served up an untapped maturity in 2023 - seven years
-
Investors still eager to snap up defensive sectors
-
Deals show investors’ constructive sentiment
